Retinitis Pigmentosa Market Revenue 2024 to 2034
Retinitis Pigmentosa Market Revenue 2024 to 2034
The retinitis pigmentosa market is predicted to expand from USD 15.81 billion in 2025 to USD 27.17 billion by 2034, growing at a CAGR of 6.2% during the forecast period from 2025 to 2034.
Report ID: 10158
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 14.89 Bn
Forecast Year,
USD USD 27.17 Bn
CAGR, 2025 -
6.2%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Retinitis Pigmentosa Market Size Analysis
Retinitis Pigmentosa Market Size By Disease Type 2024 to 2034 (USD )
| Disease Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Autosomal Dominant RP | 5.23 | 5.57 | 5.93 | 6.31 | 6.72 | 7.16 | 7.63 | 8.12 | 8.65 | 9.21 | 9.81 |
| Autosomal Recessive RP | 6.69 | 7.10 | 7.53 | 7.99 | 8.48 | 8.99 | 9.54 | 10.12 | 10.73 | 11.39 | 12.08 |
| X-linked RP | 2.97 | 3.15 | 3.33 | 3.53 | 3.74 | 3.96 | 4.20 | 4.45 | 4.71 | 4.99 | 5.29 |
Retinitis Pigmentosa Market Size By Treatment Type 2024 to 2034 (USD )
| Treatment Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vit A Supplements | 2.99 | 3.19 | 3.40 | 3.62 | 3.86 | 4.12 | 4.39 | 4.68 | 4.99 | 5.32 | 5.67 |
| Gene Therapy | 3.73 | 3.98 | 4.24 | 4.51 | 4.81 | 5.12 | 5.45 | 5.81 | 6.19 | 6.59 | 7.02 |
| Retinal Implants | 2.67 | 2.83 | 2.99 | 3.16 | 3.35 | 3.54 | 3.74 | 3.96 | 4.19 | 4.43 | 4.69 |
| Low Vision Aids | 2.24 | 2.38 | 2.54 | 2.70 | 2.87 | 3.06 | 3.26 | 3.47 | 3.69 | 3.93 | 4.18 |
| Surgery | 1.78 | 1.88 | 1.98 | 2.10 | 2.21 | 2.34 | 2.47 | 2.61 | 2.76 | 2.91 | 3.08 |
| Others | 1.48 | 1.56 | 1.65 | 1.74 | 1.84 | 1.94 | 2.05 | 2.16 | 2.28 | 2.41 | 2.54 |
Retinitis Pigmentosa Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 5.22 | 5.55 | 5.90 | 6.28 | 6.68 | 7.10 | 7.55 | 8.03 | 8.54 | 9.08 | 9.66 |
| Europe | 4.01 | 4.25 | 4.51 | 4.78 | 5.07 | 5.37 | 5.69 | 6.04 | 6.40 | 6.78 | 7.19 |
| Asia-Pacific | 3.28 | 3.50 | 3.72 | 3.96 | 4.21 | 4.49 | 4.77 | 5.08 | 5.41 | 5.76 | 6.13 |
| Latin America | 1.34 | 1.42 | 1.50 | 1.59 | 1.68 | 1.78 | 1.89 | 2.00 | 2.11 | 2.24 | 2.37 |
| Middle East & Africa | 1.04 | 1.10 | 1.16 | 1.23 | 1.30 | 1.38 | 1.46 | 1.54 | 1.63 | 1.73 | 1.83 |
Retinitis Pigmentosa Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
